Ballicules.com

Pancrelipase tablet

VIOKACE

Pronunciation: pan-kre-LI-pays

Pancrelipase tablet ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Pancrelipase tablet ballicule

What it isThe one pancrelipase without an enteric coat: a tablet (10,440 or 20,880 lipase units) that gastric acid would destroy, so the label requires a proton pump inhibitor with it.

Why this oneLabeled only for adults with exocrine pancreatic insufficiency from chronic pancreatitis or pancreatectomy — not cystic fibrosis, not children; start 500 lipase units/kg per meal, half that with snacks.

What limits itCeilings as for the class: 2,500 lipase units/kg per meal, 10,000 units/kg per day, 4,000 units per gram of dietary fat (fibrosing colonopathy above these).

Pancrelipase tablet molecular structure (skeletal formula)
Molecular structure: Pancrelipase tablet

FDA-approved for

NO BOXED WARNINGS

Principal riskNo enteric coat: gastric acid destroys it unless a proton pump inhibitor is given with it; adults with chronic pancreatitis or pancreatectomy only

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Defining liabilityHigh-dose fibrosing colonopathy and porcine-protein hypersensitivity

Open Pancrelipase tablet in the interactive console ↗